# 摘要

## Artificial intelligence for natural product drug discovery

Developments in computational omics technologies have provided new means to access the hidden diversity of natural products, unearthing new potential for drug discovery. In parallel, artifcial intelligence approaches such as machine learning have led to exciting developments in the computational drug design feld, facilitating biological activity prediction and de novo drug design for molecular targets of interest.

Here, **we describe current and future synergies between these developments** to efectively identify drug candidates from the plethora of molecules produced by nature.

计算组学技术的发展为获取天然产物的隐藏多样性提供了新的手段，为药物发现挖掘了新的潜力。与此同时，机器学习等人工智能方法在计算药物设计领域取得了令人兴奋的发展，促进了生物活性预测和针对感兴趣的分子靶点的从头药物设计。

在这里，**我们描述了这些发展之间的当前和未来的协同作用**，以有效地从自然界产生的大量分子中识别候选药物。

### 优秀表述

```
synergies: n. 协同增效效应；合并效果（synergy 的复数）
```

### 结构

首先，介绍两种技术，计算组学和机器学习技术在天然产物或药物方面的优势。

其次，介绍两种技术的协同增效作用可以帮助...

最后，还介绍了...再举个例子。

# 重要术语



```
in silico: 计算机模拟
```

